Learn More About CMT Research
Find a CMTA Center of Excellence
Get Involved with our Youth Program
Participate in a CMTA Event

CMTA News

NMD Pharma Starts Phase II Trial

Alliance Partner NMD Pharma A/S Launches Phase II SYNAPSE-CMT Trial with First Patient Dosed at CMTA Center of Excellence

Read More

CMTA Announces the INC 2025 Inherited Neuropathy Fellowship

CMTA-INC Strategic Alliance Announces the 2025 Inherited Neuropathy Fellowship

Read More

CMTA and INC forge Alliance

CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

Read More

Advances in CMT1A and CMT1B Research Through CMTA Support

Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact

Read More

Nanoparticle Gene Therapy Progress for CMT1A, CMT1B, and CMTX1

Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles

Read More

Progress Update: Early Success in Timmerman’s CMT1A Organoid Project

Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success

Read More

Alliance Partner NMD Pharma A/S Launches Phase II SYNAPSE-CMT Trial with First Patient Dosed at CMTA Center of Excellence

CMTA-INC Strategic Alliance Announces the 2025 Inherited Neuropathy Fellowship

Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact

Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles

Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success

Breakthrough in CMT1A Research: Community Efforts Drive Success of Dental Stem Cell Model

CMTA Partners with Actio Bio on CMT2C Focus Group

CMT2F Natural History Study Nears Full Recruitment as Biomarker Analysis Begins

Accelerating Research. Empowering Patients.

CMT The Greeves Family

Accelerating Research

Nearly $30 million invested in CMTA-STAR to support research projects for all CMT types.

Our Research

Empowering Patients

CMTA actively works to improve the quality of life for all CMT-affected families.

Living with CMT